Fresh analysis suggests that people who come off popular slimming jabs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who end traditional diet and exercise programs.
Research printed in a prominent health publication shows that while overweight individuals often shed about a fifth of their body weight while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing such treatments must be cognizant of the danger of fast rebound weight gain when the treatment concludes," stated expert Dr. Susan Jebb.
Such speed of regain implies a return to original weight in about a year and a half.
Weighing Therapies
The research, which examined dozens of studies involving thousands of patients, contrasted the effects of the injectable medications with other pills.
Researchers emphasize that individuals who lose weight through diet and exercise typically have a more gradual creep back—approximately 100 grams monthly—once they finish.
The Reason for the Rapid Rebound
Doctors suggest the way of the injections accounts for the amplified weight return.
The injections copy a body's own chemical called GLP-1, which helps regulate hunger.
"Sustained high doses of GLP-1 levels far above than the body's typical production might result in the system to produce less of its endogenous hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' leads to hunger is no longer kept in check, making excessive eating far more likely."
An Ongoing Condition?
Medical guidelines suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, given the likelihood of relapse, the therapy might need to be ongoing.
This perspective is echoed by pharmaceutical companies, who note that the results "emphasize the long-term character of excess weight," akin to managing diseases like hypertension.
User Testimonies
People who have stopped the medication describe a sudden return of hunger.
"It felt as if a switch activating and you become extremely hungry," described one woman.
This challenge is exacerbated if individuals have not established lasting lifestyle or habit modifications during therapy.
Widespread Interest
Survey data show that millions of people in the UK have tried these injections in the last 12 months, with demand being substantial.
- Use is greater among females than males.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
Ultimately, experts emphasize that while these medications are potent tools for weight loss, they are not a standalone cure and long-term success hinges on ongoing behavioural changes.
